Camsing Healthcare (BAC) Q1 2026 TU earnings summary

Executive summary

• Q1FY2026 revenue rose 17% YoY to S$1.251m, while the net loss narrowed to S$480k from S$669k; the Group remained in a net-liability position of S$4.319m.

• Management is reorganizing the retail portfolio, closing loss-making outlets and expanding online sales; performance improvement is expected barring unforeseen circumstances.

Financial highlights

• Revenue was S$1.251m, up 17% YoY; cost of sales rose 52% to S$607k and gross profit fell 4% to S$644k.

• Other income was S$61k versus S$50k; marketing and distribution costs fell 10% to S$844k, while administrative and other operating expenses rose 6% to S$321k.

• Loss before tax and net loss were S$480k, versus S$669k in Q1FY2025; lower marketing costs and finance costs partly offset higher administrative expenses.

• Operating cash outflow was S$200k versus S$72k; financing generated S$123k and period-end cash was S$51k.

Outlook and guidance

• Plans include developing new products, expanding sales channels and applying prudent cost management; online sales and collaborations with e-commerce operators are expected to support volume.

• Management is closing loss-making outlets and expanding online presence, and is cautiously optimistic about improved performance barring unforeseen circumstances.